A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: Case study

Inflammation and Allergy - Drug Targets

Volumn 11, Issue 5, 2012, Pages 364-368

  Zhao, Man ^a   Jiang, Jinyan ^a   Zheng, Rongrong ^a   Pearl, Henna ^b   Dickinson, Douglas ^b   Fu, Baiping ^a   Hsu, Stephen ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cold sore; Green tea polyphenol; Herpes labialis; Herpes simplex virus; Herpes stomatitis

Indexed keywords

EPIGALLOCATECHIN GALLATE; GLYCEROL;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DRUG FORMULATION; DRUG SYNTHESIS; ERYTHEMA; FEMALE; HERPES LABIALIS; HERPES SIMPLEX; HERPETIC STOMATITIS; HUMAN; MALE; MENTAL STRESS; MOUTH ULCER; RECURRENT INFECTION; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ADULT; CATECHIN; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLYCEROL; HERPES LABIALIS; HUMANS; MALE; SIMPLEXVIRUS; STEARATES;

EID: 84867711132     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152812803251033     Document Type: Article

References (11)

1. Song, J.M.; Lee K.H.; Seong, B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res., 2005, 68, 66-74.
2. Imanishi, N.; Tuji, Y.; Katada Y.; Maruhashi, M.; Konosu, S.; Mantani, N.; Terasawa, K.; Ochiai, H. Additional Inhibitory Effect of Tea Extract on the Growth of Influenza A and B Viruses in MDCK Cells. Microbiol. Immunol., 2002, 46, 491-494.
3. Xu, J.; Wang, J.; Deng, F.; Hu, Z.; Wang, H. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res., 2008, 78, 242-249.
4. Chang, L.K.; Wei, T.T.; Chiu, Y.F.; Tung, C.P.; Chuang, J.Y.; Hung, S.K.; Li, C.; Liu, S.T. Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate. Biochem. Biophys. Res. Commun., 2003, 301, 1062-1068.
5. Weber, J.M.; Ruzindana-Umunyana, A.; Imbeault, L.; Sircar, S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res., 2003, 58, 167-173.
6. Fassina, G.; Buffa, A.; Benelli, R.; Varnier, O.E.; Noonan, D.M.; Albini, A. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS, 2002, 16, 939-941.
7. Yamaguchi, K.; Honda, M.; Ikigai, H.; Hara, Y.; Shimamura, T. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res., 2002, 53, 19-34.
8. Isaacs, C.E.; Wen, G.Y.; Xu, W.; Jia, J.H.; Rohan, L.; Corbo, C.; Di Maggio, V.; Jenkins. E.C. Jr.; Hillier, S. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob. Agents Chemother., 2008, 52, 962-970.
9. Hsu, S. Green Tea and the Skin. J. Am. Acad. Dermatol., 2005, 52, 1049-1059.
10. Chen P.; Dickinson, D.; Hsu, S. Lipid-soluble green tea polyphenols: potentials for health care and consumer products. In: Helen McKinley and Mark Jamieson, eds. Handbook of Green Tea and Health Research. New York: Nova Publishers. 2009, 45-61.
11. Hsu, S.; Dickinson, D. Green tea and skin protection: mechanism of action and practical applications. Household and Personal Care. 2009: June 33-36.